Protein expression associated with early intrahepatic recurrence of hepatocellular carcinoma after curative surgery

Cancer Science

Volumn 98, Issue 5, 2007, Pages 665-673

  Yokoo, Hideki ^a,b   Kondo, Tadashi ^a   Okano, Tetsuya ^a   Nakanishi, Kazuaki ^a,b   Sakamoto, Michiie ^a,c   Kosuge, Tomoo ^d   Todo, Satoru ^b   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CHAPERONE; CYCLOPHILIN B; GLUCOSE REGULATED PROTEIN 94; LACTATE DEHYDROGENASE; LIPOCORTIN 1; LIPOCORTIN 2; LIPOCORTIN 4; PEROXIREDOXIN; PROTEASOME; PROTEIN KINASE C INHIBITOR; RIBONUCLEOPROTEIN; STATHMIN; SUPEROXIDE DISMUTASE; VINCULIN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; MASS SPECTROMETRY; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AGED; AMINO ACID SEQUENCE; CARCINOMA, HEPATOCELLULAR; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM RECURRENCE, LOCAL; PROTEINS; TIME FACTORS;

EID: 34147140335     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00441.x     Document Type: Article

References (51)

1. Nagao T, Inoue S, Yoshimi F et al. Postoperative recurrence of hepatocellular carcinoma. Ann Surg 1990; 211: 28-33.
2. Jwo SC, Chiu JH, Chau GY, Loong CC, Lui WY. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 1992; 16: 1367-71.
3. Harada T, Shigemura T, Kodama S, Higuchi T, Ikeda S, Okazaki M. Hepatic resection is not enough for hepatocellular carcinoma. A follow-up study of 92 patients. J Clin Gastroenterol 1992; 14: 245-50.
4. Nagasue N, Uchida M, Makino Y et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105: 488-94.
5. Yamamoto J, Kosuge T, Takayama T et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1996; 83: 1219-22.
6. Cha C, Fong Y, Jarnagin WR, Blumgart LH, DeMatteo RP. Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg 2003; 197: 753-8.
7. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991; 214: 114-7.
8. Kitamoto M, Nakanishi T, Kira S et al. The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis. Cancer 1993; 72: 1859-65.
9. Osada T, Sakamoto M, Ino Y et al. E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology 1996; 24: 1460-7.
10. Okada S, Shimada K, Yamamoto J et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994; 106: 1618-24.
11. Tsuda H, Zhang WD, Shimosato Y et al. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6791-4.
12. Nakanishi K, Sakamoto M, Yamasaki S, Todo S, Hirohashi S. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Cancer 2005; 103: 307-12.
13. Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma. significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer 2004; 112: 44-50.
14. Ye QH, Qin LX, Forgues M et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 2003; 9: 416-23.
15. Iizuka N, Oka M, Yamada-Okabe H et al. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 2003; 361: 923-9.
16. Yuan RH, Jeng YM, Chen HL et al. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma. J Pathol 2006; 209: 549-58.
17. Budhu A, Forgues M, YeQH et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 2006; 10: 99-111.
18. Griffin TJ, Gygi SP, Ideker T et al. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics 2002; 1: 323-33.
19. Chen G, Gharib TG, Huang CC et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 2002; 1: 304-13.
20. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999; 19: 1720-30.
21. Ding SJ, Li Y, Tan YX et al. From proteomic analysis to clinical significance: Overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol Cell Proteomics 2004; 3: 73-81.
22. Yokoo H, Kondo T, Fujii K, Yamada T, Todo S, Hirohashi S. Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells. Hepatology 2004; 40: 609-17.
23. Fujii K, Kondo T, Yokoo H, Yamada T, Iwatsuki K, Hirohashi S. Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye. Proteomics 2005; 5: 1411-22.
24. Fujii K, Kondo T, Yokoo H et al. Database of two-dimensional polyacrylamide gel electrophoresis of proteins labeled with CyDye DIGE Fluor saturation dye. Proteomics 2006; 6: 1640-53.
25. Chignard N, Shang S, Wang H et al. Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera. Gastroenterology 2006; 130: 2010-22.
26. Kuramitsu Y, Harada T, Takashima M et al. Increased expression and phosphorylation of liver glutamine synthetase in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus. Electrophoresis 2006; 27: 2998.
27. Shen H, Cheng G, Fan H et al. Expressed proteome analysis of human hepatocellular carcinoma in nude mice (LCI-D20) with high metastasis potential. Proteomics 2006; 6: 528-37.
28. Song HY, Liu YK, Feng JT et al. Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. J Cancer Res Clin Oncol 2006; 132: 92-8.
29. Ramaswamy S, Tamayo P, Rifkin R et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 2001; 98: 15 149-54.
30. Toyosaka A, Okamoto E, Mitsunobu M, Oriyama T, Nakao N, Miura K. Intrahepatic metastases in hepatocellular carcinoma: Evidence for spread via the portal vein as an efferent vessel. Am J Gastroenterol 1996; 91: 1610-15.
31. Regimbeau JM, Abdalla EK, Vauthey JN et al. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol 2004; 85: 36-41.
32. Snell K. Fell DA. Metabolic control analysis of mammalian serine metabolism. Adv Enzyme Regul 1990; 30: 13-32.
33. Snell K, Weber G. Enzymic imbalance in serine metabolism in rat hepatomas. Biochem J 1986; 233: 617-20.
34. Snell K. Enzymes of serine metabolism in normal, developing and neoplastic rat tissues. Adv Enzyme Regul 1984; 22: 325-400.
35. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: From genes to environment. Nat Rev Cancer 2006; 6: 674-87.
36. Misek DE, Chang CL, Kuick R et al. Transforming properties of a Q18->E mutation of the microtubule regulator Op18. Cancer Cell 2002; 2: 217-28.
37. Chen G, Gharib TG, Wang H et al. Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci USA 2003; 100: 13 537-42.
38. Blanc JF, Lalanne C, Plomion C et al. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 2005; 5: 3778-89.
39. Annabi B, Currie JC, Bouzeghrane M et al. Contribution of the 37-kDa laminin receptor precursor in the anti-metastatic PSP94-derived peptide PCK3145 cell surface binding. Biochem Biophys Res Commun 2006; 346: 358-66.
40. Choi JH, Kim TN, Kim S et al. Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas. Anticancer Res 2002; 22: 3331-5.
41. Zhu XD, Li CL, Lang ZW, Gao GF, Tien P. Significant correlation between expression level of HSP gp96 and progression of hepatitis B virus induced diseases. World J Gastroenterol 2004; 10: 1141-5.
42. Masaki T, Tokuda M, Ohnishi M et al. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma. Hepatology 1996; 24: 72-81.
43. Huang C, Wu M. Superoxide dismutase activity in tissues from 19 cases of hepatocellular carcinoma. Zhonghua Yi Xue Za Zhi 1990; 70: 138-9, 12.
44. Stenner-Liewen F, Luo G, Sahin U et al. Definition of tumor-associated antigens in hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2000; 9: 285-90.
45. Lim SO, Park SJ, Kim W et al. Proteome analysis of hepatocellular carcinoma. Biochem Biophys Res Commun 2002; 291: 1031-7.
46. Li C, Tan YX, Zhou H et al. Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers. Proteomics 2005; 5: 1125-39.
47. Pang R, Yuen J, Yuen MF et al. PIN1 overexpression and beta-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma. Oncogene 2004; 23: 4182-6.
48. Yokota S, Yamamoto Y, Shimizu K et al. Increased expression of cytosolic chaperonin CCT in human hepatocellular and colonic carcinoma. Cell Stress Chaperones 2001; 6: 345-50.
49. Zheng S, Ruan Y, Wu Z, Tang J. The relationship between; 67KD: Laminin receptor expression and metastasis of hepatocellular carcinoma. J Tongji Med University 1997; 17: 200-2, 24.
50. Gorg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004; 4: 3665-85.
51. Kondo T, Hirohashi S. Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics. Nat Protoc 2007; 1: 2940-56.